In the basal-like subtype breast cancers, they are usually triple-negative, i.e., they lack the estrogen receptor (ER), the progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) [16]. This evidence concerns the gene PGR and breast carcinoma.